Back to mobile site

Sangamo Biosciences (SGMO) Tops Q1 EPS by 3c

May 10, 2017 4:03 PM EDT

Sangamo Biosciences (NASDAQ: SGMO) reported Q1 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $3.43 million versus the consensus estimate of $4.25 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings